Promius Pharma, LLC – Product Pipeline Review

Global Markets Direct’s, ‘Promius Pharma, LLC – Product Pipeline Review – 2016’, provides an overview of the Promius Pharma, LLC’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Promius Pharma, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Promius Pharma, LLC

The report provides overview of Promius Pharma, LLC including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Promius Pharma, LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Promius Pharma, LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Promius Pharma, LLC’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Promius Pharma, LLC

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Promius Pharma, LLC’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Promius Pharma, LLC Snapshot 6

Promius Pharma, LLC Overview 6

Key Information 6

Key Facts 6

Promius Pharma, LLC - Research and Development Overview 7

Key Therapeutic Areas 7

Promius Pharma, LLC - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Promius Pharma, LLC - Pipeline Products Glance 12

Promius Pharma, LLC - Late Stage Pipeline Products 12

Pre-Registration Products/Combination Treatment Modalities 12

Phase III Products/Combination Treatment Modalities 13

Promius Pharma, LLC - Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Phase I Products/Combination Treatment Modalities 15

Promius Pharma, LLC - Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Promius Pharma, LLC - Drug Profiles 17

DFD-01 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

DFN-11 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

tetracycline MR 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

DFD-06 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

DFD-10 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

DFN-02 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

ACT-01 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

celecoxib 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

DFN-10 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

DFN-15 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

DFN-14 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

DFN-19 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

DFD-04 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

DFD-05 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

DFD-08 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Small Molecules 1 for Epilepsy 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Small Molecules 1 for Parkinson's Disease 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Small Molecules 2 for Epilepsy 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Small Molecules 2 for Parkinson's Disease 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Small Molecules 3 for Epilepsy 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Small Molecules 3 for Parkinson's Disease 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Small Molecules 4 for Epilepsy 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

Small Molecules 4 for Parkinson's Disease 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

Promius Pharma, LLC - Pipeline Analysis 40

Promius Pharma, LLC - Pipeline Products by Target 40

Promius Pharma, LLC - Pipeline Products by Route of Administration 41

Promius Pharma, LLC - Pipeline Products by Molecule Type 42

Promius Pharma, LLC - Pipeline Products by Mechanism of Action 43

Promius Pharma, LLC - Recent Pipeline Updates 44

Promius Pharma, LLC - Dormant Projects 45

Promius Pharma, LLC - Locations And Subsidiaries 46

Head Office 46

Appendix 47

Methodology 47

Coverage 47

Secondary Research 47

Primary Research 47

Expert Panel Validation 47

Contact Us 47

Disclaimer 48

List of Tables

List of Tables

Promius Pharma, LLC, Key Information 6

Promius Pharma, LLC, Key Facts 6

Promius Pharma, LLC – Pipeline by Indication, 2016 8

Promius Pharma, LLC – Pipeline by Stage of Development, 2016 10

Promius Pharma, LLC – Monotherapy Products in Pipeline, 2016 11

Promius Pharma, LLC – Pre-Registration, 2016 12

Promius Pharma, LLC – Phase III, 2016 13

Promius Pharma, LLC – Phase II, 2016 14

Promius Pharma, LLC – Phase I, 2016 15

Promius Pharma, LLC – Preclinical, 2016 16

Promius Pharma, LLC – Pipeline by Target, 2016 40

Promius Pharma, LLC – Pipeline by Route of Administration, 2016 41

Promius Pharma, LLC – Pipeline by Molecule Type, 2016 42

Promius Pharma, LLC – Pipeline Products by Mechanism of Action, 2016 43

Promius Pharma, LLC – Recent Pipeline Updates, 2016 44

Promius Pharma, LLC – Dormant Developmental Projects,2016 45

List of Figures

List of Figures

Promius Pharma, LLC – Pipeline by Indication, 2016 8

Promius Pharma, LLC – Pipeline by Stage of Development, 2016 10

Promius Pharma, LLC – Monotherapy Products in Pipeline, 2016 11

Promius Pharma, LLC – Pipeline by Target, 2016 40

Promius Pharma, LLC – Pipeline by Route of Administration, 2016 41

Promius Pharma, LLC – Pipeline by Molecule Type, 2016 42

Promius Pharma, LLC – Pipeline Products by Mechanism of Action, 2016 43

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports